Cargando…
A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS)
OBJECTIVE: A1C is an optional method for diagnosing diabetes and also for detecting individuals at increased risk of the disease. However, how A1C compares with fasting (FPG) and 2-h plasma glucose for detecting at-risk individuals is not well known. RESEARCH DESIGN AND METHODS: A 2-h glucose tolera...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928372/ https://www.ncbi.nlm.nih.gov/pubmed/20573754 http://dx.doi.org/10.2337/dc10-0679 |
_version_ | 1782185862199508992 |
---|---|
author | Lorenzo, Carlos Wagenknecht, Lynne E. Hanley, Anthony J.G. Rewers, Marian J. Karter, Andrew J. Haffner, Steven M. |
author_facet | Lorenzo, Carlos Wagenknecht, Lynne E. Hanley, Anthony J.G. Rewers, Marian J. Karter, Andrew J. Haffner, Steven M. |
author_sort | Lorenzo, Carlos |
collection | PubMed |
description | OBJECTIVE: A1C is an optional method for diagnosing diabetes and also for detecting individuals at increased risk of the disease. However, how A1C compares with fasting (FPG) and 2-h plasma glucose for detecting at-risk individuals is not well known. RESEARCH DESIGN AND METHODS: A 2-h glucose tolerance test, frequently sampled intravenous glucose tolerance test, and A1C were obtained at the follow-up examination in 855 participants in the Insulin Resistance Atherosclerosis Study (IRAS). For this report, 385 individuals were at increased risk of diabetes as defined by A1C between 5.7 and 6.4%, impaired glucose tolerance (IGT), and/or impaired fasting glucose (IFG). RESULTS: IFG and IGT identified 69.1 and 59.5% of all individuals at increased risk of diabetes, respectively. A1C 5.7–6.4% detected 23.6% of all at-risk individuals, although more African Americans (31.4%) and Hispanics (35.2%) than non-Hispanic whites (9.9%). Relative to A1C, FPG was more strongly related to fasting insulin (r = 0.38 vs. 0.26; P < 0.01), acute insulin response (r = – 0.20 vs. – 0.09; P < 0.01), and waist circumference (r = 0.43 vs. 0.25; P < 0.001) by the Spearman correlation test. Similarly, 2-h plasma glucose was more strongly related to Si (r = – 0.40 vs. – 0.27; P < 0.01) and triglycerides (r = 0.30 vs. 0.08; P < 0.001). CONCLUSIONS: A1C 5.7–6.4% is less sensitive for detecting at-risk individuals than IFG and IGT, particularly among non-Hispanic whites. Single determinations of FPG and 2-h plasma glucose seem to be more precise correlates of insulin resistance and secretion than A1C and, in general, better for other metabolic disorders. |
format | Text |
id | pubmed-2928372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-29283722011-09-01 A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS) Lorenzo, Carlos Wagenknecht, Lynne E. Hanley, Anthony J.G. Rewers, Marian J. Karter, Andrew J. Haffner, Steven M. Diabetes Care Original Research OBJECTIVE: A1C is an optional method for diagnosing diabetes and also for detecting individuals at increased risk of the disease. However, how A1C compares with fasting (FPG) and 2-h plasma glucose for detecting at-risk individuals is not well known. RESEARCH DESIGN AND METHODS: A 2-h glucose tolerance test, frequently sampled intravenous glucose tolerance test, and A1C were obtained at the follow-up examination in 855 participants in the Insulin Resistance Atherosclerosis Study (IRAS). For this report, 385 individuals were at increased risk of diabetes as defined by A1C between 5.7 and 6.4%, impaired glucose tolerance (IGT), and/or impaired fasting glucose (IFG). RESULTS: IFG and IGT identified 69.1 and 59.5% of all individuals at increased risk of diabetes, respectively. A1C 5.7–6.4% detected 23.6% of all at-risk individuals, although more African Americans (31.4%) and Hispanics (35.2%) than non-Hispanic whites (9.9%). Relative to A1C, FPG was more strongly related to fasting insulin (r = 0.38 vs. 0.26; P < 0.01), acute insulin response (r = – 0.20 vs. – 0.09; P < 0.01), and waist circumference (r = 0.43 vs. 0.25; P < 0.001) by the Spearman correlation test. Similarly, 2-h plasma glucose was more strongly related to Si (r = – 0.40 vs. – 0.27; P < 0.01) and triglycerides (r = 0.30 vs. 0.08; P < 0.001). CONCLUSIONS: A1C 5.7–6.4% is less sensitive for detecting at-risk individuals than IFG and IGT, particularly among non-Hispanic whites. Single determinations of FPG and 2-h plasma glucose seem to be more precise correlates of insulin resistance and secretion than A1C and, in general, better for other metabolic disorders. American Diabetes Association 2010-09 2010-06-23 /pmc/articles/PMC2928372/ /pubmed/20573754 http://dx.doi.org/10.2337/dc10-0679 Text en © 2010 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details. |
spellingShingle | Original Research Lorenzo, Carlos Wagenknecht, Lynne E. Hanley, Anthony J.G. Rewers, Marian J. Karter, Andrew J. Haffner, Steven M. A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS) |
title | A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS) |
title_full | A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS) |
title_fullStr | A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS) |
title_full_unstemmed | A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS) |
title_short | A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS) |
title_sort | a1c between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the insulin resistance atherosclerosis study (iras) |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928372/ https://www.ncbi.nlm.nih.gov/pubmed/20573754 http://dx.doi.org/10.2337/dc10-0679 |
work_keys_str_mv | AT lorenzocarlos a1cbetween57and64asamarkerforidentifyingprediabetesinsulinsensitivityandsecretionandcardiovascularriskfactorstheinsulinresistanceatherosclerosisstudyiras AT wagenknechtlynnee a1cbetween57and64asamarkerforidentifyingprediabetesinsulinsensitivityandsecretionandcardiovascularriskfactorstheinsulinresistanceatherosclerosisstudyiras AT hanleyanthonyjg a1cbetween57and64asamarkerforidentifyingprediabetesinsulinsensitivityandsecretionandcardiovascularriskfactorstheinsulinresistanceatherosclerosisstudyiras AT rewersmarianj a1cbetween57and64asamarkerforidentifyingprediabetesinsulinsensitivityandsecretionandcardiovascularriskfactorstheinsulinresistanceatherosclerosisstudyiras AT karterandrewj a1cbetween57and64asamarkerforidentifyingprediabetesinsulinsensitivityandsecretionandcardiovascularriskfactorstheinsulinresistanceatherosclerosisstudyiras AT haffnerstevenm a1cbetween57and64asamarkerforidentifyingprediabetesinsulinsensitivityandsecretionandcardiovascularriskfactorstheinsulinresistanceatherosclerosisstudyiras |